{"id":98306,"date":"2024-01-16T12:40:03","date_gmt":"2024-01-16T07:10:03","guid":{"rendered":"http:\/\/finservwealth.com\/ubs-downgrades-syngene-to-ae%cb%9csellae-on-weak-outlook-shares-slip-3\/"},"modified":"2024-01-16T12:40:03","modified_gmt":"2024-01-16T07:10:03","slug":"ubs-downgrades-syngene-to-ae%cb%9csellae-on-weak-outlook-shares-slip-3","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/ubs-downgrades-syngene-to-ae%cb%9csellae-on-weak-outlook-shares-slip-3\/","title":{"rendered":"UBS downgrades Syngene to \u00e2\u20ac\u02dcsell\u00e2\u20ac\u2122 on weak outlook, shares slip 3%"},"content":{"rendered":"<p> The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS.<\/p><div id=\"finse-2392322175\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/ubs-downgrades-syngene-to-%C3%A2%E2%82%AC%CB%9Csell%C3%A2%E2%82%AC%E2%84%A2weak-outlook-shares-slip-3_17400671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS. The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/ubs-downgrades-syngene-to-%C3%A2%E2%82%AC%CB%9Csell%C3%A2%E2%82%AC%E2%84%A2weak-outlook-shares-slip-3_17400671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/ubs-downgrades-syngene-to-%C3%A2%E2%82%AC%CB%9Csell%C3%A2%E2%82%AC%E2%84%A2weak-outlook-shares-slip-3_17400671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS. The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/buzzing-stocks\/ubs-downgrades-syngene-to-%C3%A2%E2%82%AC%CB%9Csell%C3%A2%E2%82%AC%E2%84%A2weak-outlook-shares-slip-3_17400671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The outlook for Syngene looks weak on a tough marco situation, global headwinds and falling VC funding, said UBS.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-98306","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2022\/200x200\/S\/Syngene_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/98306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=98306"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/98306\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=98306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=98306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=98306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}